The US is facing a drug shortage crisis as recalls related to drug manufacturing quality are increasing, leading to common shortages. The government is giving out vouchers worth over $100 million to companies for drugs that bring in billions for Big Pharma. The Affordable Drug Manufacturing Act proposed by SenWarren aims to address drug shortages by allowing the government to manufacture drugs when the market fails. GlaxoSmithKline and Amneal are withdrawing patents on key medicines in response to FTC's letters, making it easier for generics to enter and lower prices for Americans.
Cheap generic drugs have saved American taxpayers and consumers hundreds of billions of dollars a year. But recalls related to drug manufacturing quality are becoming increasingly common. And drug shortages have become the norm. Read the whole story here: https://t.co/j4t0i0BlYY https://t.co/QD1b960gCb
Cheap generic drugs have saved American taxpayers and consumers hundreds of billions of dollars a year. But recalls related to drug manufacturing quality are becoming increasingly common. And drug shortages have become the norm. Read the whole story here: https://t.co/AmhReeBKz6 https://t.co/koHY53XpW4
In response to @FTC's letters, GlaxoSmithKline is withdrawing its patents on inhalers and Amneal is withdrawing its patents on an epinephrine product—making it easier for generics to enter and lower prices for Americans who depend on these key medicines. https://t.co/DpHuo7cbbw https://t.co/gLj4TdSliS
Cheap generic drugs have saved American taxpayers and consumers hundreds of billions of dollars a year. But recalls related to drug manufacturing quality are becoming increasingly common. And drug shortages have become the norm. Read the whole story here: https://t.co/AmhReeBKz6 https://t.co/oNHgiMIqBD
The US government is giving out vouchers worth more than $100 million to companies for drugs that bring in billions for Big Pharma, a Bloomberg analysis found https://t.co/kWmfxJJGVx
This year, drug shortages reached their highest point in nearly a decade. That's devastating. A big shortage risk occurs when just a few companies make a drug. My Affordable Drug Manufacturing Act lets the government make these drugs when the market fails. It's a no brainer. https://t.co/JPmYXPhlbe